Phosphatidylethanolamine-binding protein 1
Actin-like protein (12-21) is a synthetic peptide fragment corresponding to amino acid residues 12 through 21 of an actin-like protein sequence. As a peptide compound, it serves as a valuable tool for exploring the structural and functional motifs of actin and actin-related proteins. The segment encapsulates a region that is often implicated in protein-protein interactions, cytoskeletal dynamics, and intracellular signaling pathways, making it particularly significant for studies focusing on the molecular basis of cytoskeletal organization and dynamics. Its defined sequence and biochemical properties support a range of advanced research applications in cell biology, structural biochemistry, and peptide-based assay development.
Peptide mapping: Researchers employ this peptide fragment in peptide mapping studies to dissect the structural domains of actin and actin-like proteins. By isolating and analyzing specific regions such as residues 12-21, it is possible to pinpoint critical motifs responsible for protein folding, stability, and intermolecular interactions. This targeted approach aids in elucidating the conformational landscape of actin, facilitating a deeper understanding of its role within the cytoskeleton and its interactions with binding partners.
Epitope characterization: The defined sequence of residues 12-21 is frequently utilized in epitope mapping and antibody development projects. By serving as a representative epitope, the peptide enables scientists to identify, characterize, and validate antibody specificity against actin-like proteins. This application is particularly relevant for generating monoclonal or polyclonal antibodies for use in immunodetection assays, Western blotting, and immunoprecipitation protocols, where precise recognition of actin domains is essential for reliable experimental outcomes.
Protein interaction studies: The actin-like protein (12-21) peptide is instrumental in probing interactions between actin or actin-related proteins and their cellular partners. Researchers can use the peptide in binding assays, surface plasmon resonance (SPR), or pull-down experiments to assess affinity and specificity of interacting molecules. Such studies provide valuable insights into the molecular mechanisms governing cytoskeletal assembly, regulation, and signal transduction, supporting the identification of novel interaction networks and regulatory factors.
Peptide-based assay development: The sequence-specific nature of this peptide fragment makes it an ideal standard or substrate in the development and optimization of peptide-based assays. It can be incorporated into enzyme activity assays, protease susceptibility tests, or competitive binding formats to evaluate the activity of enzymes or inhibitors targeting actin-related sequences. This application enhances assay sensitivity, specificity, and reproducibility, contributing to robust experimental designs in biochemical and cell biological research.
Structural biology research: The actin-like protein (12-21) peptide is also valuable in structural studies aimed at understanding the conformational features of actin-derived sequences. By analyzing the peptide using techniques such as nuclear magnetic resonance (NMR) spectroscopy or circular dichroism (CD), scientists can gain insights into secondary structure propensities, folding behavior, and the influence of sequence context on peptide conformation. These findings inform broader investigations into actin structure-function relationships and support the rational design of peptide mimetics or inhibitors targeting cytoskeletal proteins.
3. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More